New study tracks Real-Life impact of friedreich ataxia via smartphone app

NCT ID NCT05943002

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

The PROFA study is an international observational study that follows 200 people with Friedreich Ataxia (FA) across Germany, Austria, and France. Participants use a mobile app to report their quality of life, symptoms, and healthcare costs daily for six months. The goal is to understand the real-world challenges of FA, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
This study could reveal how Friedreich Ataxia truly affects daily life and finances, helping design better support and future treatments.
What could go wrong
This is an observational study, not a treatment trial. It won't test any drug or therapy, so it cannot directly improve symptoms or cure the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRIEDREICH ATAXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Neurology, RWTH Aachen University

    RECRUITING

    Aachen, 52074, Germany

  • Friedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik

    RECRUITING

    Münich, 80336, Germany

  • German Center for Neuro-degenerative Diseases (DZNE)

    RECRUITING

    Bonn, 53127, Germany

  • Klinik für Neurologie, Medizinische Universität Innsbruck

    RECRUITING

    Innsbruck, 6020, Austria

  • Neurologische Klinik und Hertie-Institut für Klinische Hirnforschung, Universitätsklinik Tübingen

    NOT_YET_RECRUITING

    Tübingen, 72076, Germany

  • Paris Brain Institute

    RECRUITING

    Paris, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.